NH Value Care—Accountable Care Organization (ACO)—Quality Performance Results
2020 Quality Performance Results:
| ACO Quality Measure Number |
Measure Name |
Rate |
ACO Mean |
ACO-43
|
Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) |
1.16% |
0.95% |
| ACO-13 |
Falls: Screening for Future Fall Risk |
66.54% |
84.97% |
| ACO-14 |
Preventive Care and Screening: Influenza Immunization |
65.45% |
76.03% |
| ACO-17 |
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention |
64.29% |
81.67% |
| ACO-18 |
Preventive Care and Screening: Screening for Depression and Follow-up Plan |
56.55% |
71.46% |
| ACO-19 |
Colorectal Cancer Screening |
71.88% |
72.59% |
| ACO-20 |
Breast Cancer Screening |
70.28% |
74.05% |
| ACO-42 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
70.63% |
83.37% |
| ACO-27 |
Diabetes: Hemoglobin A1c Poor Control (>9%) |
15.35% |
14.70% |
| ACO-28 |
HTN (HTN): Controlling High Blood Pressure |
74.80% |
72.87% |
| |
|
|
|
| |
“Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.”
|
|
|